affects women at a young age
Dr. Umm al-Khair Abdullah Abu al-Khair, consultant oncologist and assistant professor at King Saud bin Abdulaziz University for Health Sciences in the Kingdom of Saudi Arabia, confirmed during the Pan Arab Cancer Association conference “PAN ARAB CANCER” under the title of the Arab World Against Cancer that the gene that causes breast cancer or hereditary breast cancer represents 10% of breast cancer, while cancer of unknown cause is the rest.
Dr. Umm Al-Khair Abdullah said during the conference of the Arab Cancer Association headed by Dr. Mustafa Al-Serafy that hereditary breast cancer is the result of a defect in the genetic code, explaining that the most common gene for this type of genetic cancer is Braka 1 and Braka 2, explaining that they are the oldest genes that cause breast cancer hereditary And that hereditary breast cancer is characterized by that it affects women at an early age and the tumor is more aggressive than other types, and is more able to spread.
She explained that women who carry the gene are more likely to develop ovarian cancer, and that the incidence of breast cancer and ovarian cancer is high compared to other people who do not have this gene.
And she confirmed that those who carry the Braka 2 gene are more likely to have pancreatic and prostate cancer among men, so while the percentage of breast cancer in men without this gene is less than 1%, the percentage increases to 6 times in men who carry this gene to reach 6%, explaining that it is necessary Knowing women with this gene because of its effect on treatment and follow-up in the future, its knowledge is important for determining the future treatment plan.
She said that it is possible to resort to surgery before the tumor and carriers of the gene and the removal of the breasts by plastic surgery or to do periodic magnetic resonance examination from the age of 25 years to 30 years, and after thirty years, it is possible to mix between magnetic resonance and mammogram rays, indicating that there are drugs that play the role of protection against cancer. Breast, such as using the drug "tamexafin", which may have a benefit for prevention to some extent, of course, since this gene increases the possibility of ovarian cancer, it is recommended to remove the ovaries from after the age of 35 to 40 years after the completion of childbearing.
